Nucleic acids are one of several macromolecules found in the body in addition to fats, proteins, and carbohydrates. A nucleic acid is a polymer composed of four nucleotides linked together in a long chain known as polynucleotide. A nucleic acid consists of DNA, RNA, and protein. Nucleic acid extraction and purification is widely used in next generation sequencing, nucleic acid library preparation, gene therapy research and various other areas such as plant and animal tissue culture. Genome analysis in cloning, drug discovery, disease diagnosis, and stem cell research has increased considerably in the recent past. Increased research and developmental activities undertaken by pharmaceutical companies have resulted in the launch of better biological drugs.
The rising demand for pure nucleic acids in pharmaceutical and biotechnological industries and growing use of nucleic acid-based tests in diagnosis have propelled the growth of this market across the globe. Increasing applications of these techniques in various fields such as genetic engineering, life science research, forensics and molecular diagnostics, and government funding in R&D, and recent technological innovations are expected to fuel the growth of this market. Oncology, neurological diseases, and autoimmune diseases have been key focus areas in personalized medicine. According to Cancer Research U.K., over 14 million adults were diagnosed with some type of cancer in 2012 globally. The data further states that more than 8 million mortalities were recorded in 2012 due to cancer. Such high prevalence of cancer has demanded better therapeutic alternatives with fewer side effects. Autoimmune diseases are another major concern, as scientists have been unsuccessful in finding cure for these diseases. According to American Autoimmune Related Diseases Association, Inc., in the U.S., over 23 million individuals suffer from autoimmune disease.
The nucleic acid extractors market is segmented by product type, application, end user, and geography. Based on product, the market is segmented into semi-automatic nucleic acid extractors and fully-automatic nucleic acid extractors. Based on application, the market is segmented into genomic DNA extraction, blood DNA extraction, RNA extraction, and plasmid DNA extraction. Based on end user, the segmentation includes academic research, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, and other.
Based on geography, the global nucleic acid extractors market is segmented into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016, owing to the large academic and pharmaceutical customer base. Various pharmaceutical giants have their research facilities in the U.S. Some of these include Novartis, GSK, Pfizer, Bristol-Myers Squibb, and Ionis Pharmaceuticals. Europe is expected to be the second largest market in terms of revenue and the market is expected to grow during the forecast period due to rapid economic development and increase in health care expenditure in this region. Asia Pacific is expected to register high growth during 2017-2025, due to factors such as increasing R&D expenditure and technological advancements in countries in the region. In Middle East & Africa, and Latin America, healthcare projects and growing economies drives the market of nucleic acid extractors.
Some of the key players operating in the global nucleic acid extractors market include ELITechGroup, Analytik Jena AG, AUTOGEN Inc., Bio-Rad Laboratories, Inc., Hamilton Company, Promega Corporation, and TBG Diagnostics Limited.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.